OSSFF (Embla Medical hf) Total Debt per Share: $1.29 (As of Mar. 2026)


OSSFF Embla Medical hf OSSFF
92 GF Score
Price $4.15
GF Value $5.32
! 2 Warning Signs
View Full Analysis

What is Embla Medical hf Total Debt per Share?

Embla Medical hf OSSFF 92 Total Debt per Share is $1.29 as of Mar. 2026. GuruFocus rates OSSFF with a GF Score™ of 92/100 and a GF Value™ of $5.32. The stock has 2 warning signs investors should review.

$1.29 (As of Mar. 2026)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Embla Medical hf's Total Debt Per Share for the quarter that ended in Mar. 2026 was $1.29.


Embla Medical hf Total Debt per Share Historical Data

* Premium members only.

The historical data trend for Embla Medical hf's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Embla Medical hf Total Debt per Share Chart

Embla Medical hf Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Debt per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.06 1.14 1.11 1.17 1.27

Embla Medical hf Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.24 1.33 1.31 1.27 1.29
OSSFF
92GF Score
Embla Medical hf OSSFF
Total Debt per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Embla Medical hf Total Debt per Share Calculation

Embla Medical hf's Total Debt Per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Embla Medical hf's Total Debt Per Share for the quarter that ended in Mar. 2026 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Debt per Share →
What does a Total Debt per Share of $1.29 mean?
Embla Medical hf (OSSFF) has a Total Debt per Share of $1.29 as of Mar. 2026. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Embla Medical hf and its competitors.
Is Embla Medical hf's Total Debt per Share too high?
Embla Medical hf's current Total Debt per Share is $1.29. Overall, Embla Medical hf has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Embla Medical hf's Total Debt per Share compare to ABT and SYK?
Embla Medical hf's Total Debt per Share of $1.29 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Debt per Share for a Medical Devices & Instruments company?
A good Total Debt per Share depends on the Medical Devices & Instruments industry context. However, Total Debt per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Debt per Share mean?
A high Total Debt per Share can signal that a stock is expensive relative to its fundamentals. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Embla Medical hf and its competitors. Embla Medical hf's current Total Debt per Share is $1.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embla Medical hf stock overvalued right now?
Embla Medical hf (OSSFF) has a current Total Debt per Share of $1.29. The stock's GF Value™ is $5.32, compared to a current price of $4.15 — trading 22% below its estimated fair value. The current Total Debt per Share is $1.29. Embla Medical hf's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Debt per Share calculated?
Total Debt per Share is calculated from a company's financial statements. For Embla Medical hf (OSSFF), the current Total Debt per Share is $1.29 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Embla Medical hf (OSSFF) Overvalued in 2026?

Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued. The current stock price of $4.15 is trading 22% below its estimated GF Value™ of $5.32.

Key valuation signals for OSSFF:

  • Total Debt per Share: $1.29
  • GF Value™: $5.32 vs. price of $4.15 (22% below fair value)
  • GF Score™: 92/100 with 2 warning signs

No single metric tells the full story. See the OSSFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Embla Medical hf Business Description

Address Grjothals 5, Reykjavik, ISL
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
92GF Score

Get the complete analysis for OSSFF

Total Debt per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.15
Price
$5.32
GF Value